Salary Details for a Clinical Research Associate II at BD in Minneapolis-St. Paul, MN
- United States
- Any Experience
- 0-1 Years
- 1-3 Years
- 4-6 Years
- 7-9 Years
- 10-14 Years
- 15+ Years
$93K
/yrThe estimated total pay for a Clinical Research Associate II at BD is $93,382 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The estimated base pay is $87,569 per year. The estimated additional pay is $5,813 per year. Additional pay could include bonus, stock, commission, profit sharing or tips. The "Most Likely Range" represents values that exist within the 25th and 75th percentile of all pay data available for this role.
How accurate is this most likely Total Pay range (base + additional) of $79K-$111K/yr?
Related Searches: All Clinical Research Associate II Salaries | All BD Salaries
Check out real people talking anonymously about pay
If you have a 200k+ in salary at your current job with zero WLB, and you have an offer that is less than half but with work only 4 hours a day, would you take it?
Discuss Clinical Research Associate II Pay with the Community
Engage in conversations about Clinical Research Associate II pay with other professionals in the community.
Got a burning question about pay at BD? Just ask!
On Glassdoor, you can share insights and advice anonymously with BD employees and get real answers from people on the inside.
BD Salary FAQs
The average salary for a Clinical Research Associate II is $91,746 per year in Minneapolis-St. Paul, MN, which is 1% lower than the average BD salary of $93,382 per year for this job.
The salary trajectory of a Clinical Research Associate II ranges between locations and employers. The salary starts at $78,067 per year and goes up to $135,053 per year for the highest level of seniority.
Popular Careers with BD Job Seekers
BD Benefits
- 401K Plan(85 comments)
“Match per dollar is low, considering that there is no ESPP and the retirement plan is going away in 2024.”
